H.P. Acthar Gel and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with H.P. Acthar Gel (corticotropin).
Corticotropin High Blood Pressure (Hypertension)
Major Potential Hazard, Moderate plausibility
ACTH - fluid retention
Adrenocorticotropic agents may cause hypernatremia, hypokalemia, fluid retention, and elevation in blood pressure. Therapy with these agents, particularly if intended for longer than brief periods, should be administered cautiously in patients with preexisting fluid retention or conditions that may be aggravated by these effects. Dietary sodium restriction and potassium supplementation may be advisable. The manufacturers consider the use of adrenocorticotropic agents to be contraindicated in patients with congestive heart failure or uncontrolled hypertension.
Switch to professional interaction data
H.P. Acthar Gel drug interactions
There are 390 drug interactions with H.P. Acthar Gel (corticotropin).
H.P. Acthar Gel disease interactions
There are 20 disease interactions with H.P. Acthar Gel (corticotropin) which include:
- (+) tuberculin test
- adrenal insufficiency
- electrolyte imbalance
- fluid retention
- GI perforation
- hyperadrenocorticism
- infections
- ocular herpes simplex
- osteoporosis
- PUD
- scleroderma
- vaccination
- cirrhosis
- depression/psychoses
- diabetes
- elevated IOP
- hypothyroidism
- myasthenia gravis
- myopathy
- thromboembolism
Report options
More about H.P. Acthar Gel (corticotropin)
- H.P. Acthar Gel consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: corticotropin
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Benlysta
Benlysta is used for active systemic lupus erythematosus (SLE) or lupus nephritis in adults and ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Kesimpta
Kesimpta is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.